Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Shinichi Antoku"'
Autor:
Hiroyuki Ito, Hideyuki Inoue, Takuma Izutsu, Suzuko Matsumoto, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0292014 (2023)
BackgroundThe changes in the estimated glomerular filtration rate (eGFR) and predictors of the renal prognosis were retrospectively assessed over the 12 months after the initiation of tofogliflozin, which has the shortest half-life among sodium-gluco
Externí odkaz:
https://doaj.org/article/2645d2cc4d5e4eabbb17471d488cc69c
Autor:
Hiroyuki Ito, Suzuko Matsumoto, Takuma Izutsu, Eiji Kusano, Jiro Kondo, Hideyuki Inoue, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248577 (2021)
AimsThe safety and efficacy, particularly, the factors associated with the renal prognosis, were assessed over 12 months after the initiation of luseogliflozin therapy in Japanese patients with type 2 diabetes and renal impairment.MethodsIn total, 23
Externí odkaz:
https://doaj.org/article/3777f0c81bbe46ffb9c83eb11445e18c
Autor:
Hiroyuki, Ito, Kiyoko, Ito, Mahika, Tanaka, Mayumi, Hokamura, Mari, Tanaka, Eiji, Kusano, Jiro, Kondo, Takuma, Izutsu, Suzuko, Matsumoto, Hideyuki, Inoue, Shinichi, Antoku, Tomoko, Yamasaki, Toshiko, Mori, Michiko, Togane
Publikováno v:
Internal Medicine. 61:1309-1317
Objective Diabetes is recognized as an underlying disease of constipation. However, the prevalence of constipation varies according to the diagnostic criteria applied. We investigated the prevalence of constipation based on the new guideline for cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1642472026a8e09af99ec3319f0401
https://doi.org/10.2169/internalmedicine.7676-21
https://doi.org/10.2169/internalmedicine.7676-21
Autor:
Satoshi Iwata, Naoki Miyao, Takashi Naka, Takatomo Hirouchi, Atsushi Nakagawa, Yoshihiko Matsumoto, Yutaka Tokue, Jiro Terada, Kenji Tsushima, Kazutoshi Hiyama, Eri Hagiwara, Daiki Kanou, Shuichi Kawano, Tsutomu Sakurai, Yuko Komase, Yuji Hirai, Masahiro Shinoda, Shinichiro Ota, Mikio Takamori, Yoshitaka Yamazaki, Mitsunaga Iwata, Shingo Tanaka, Ichiro Kawada, Sho Fujiwara, Norihito Tarumoto, Kenya Ie, Shinichi Antoku, Naho Kagiyama, Megumi Shimada, Yujiro Uchida, Hiroyuki Kunishima, Osamu Kobayashi, Kazumasa Harada, Takeshi Saraya, Yasuhiro Gon, Yoshihiko Ogawa, Takashi Ogura, Masaharu Shinkai, Hidefumi Koh
Publikováno v:
Infectious Diseases and Therapy
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded RNA virus. Favipiravir is an orally administrable antiviral drug whose mechanism of action i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333dde16f8386b3b4fa6183aa9418f20
https://doi.org/10.1007/s40121-021-00517-4
https://doi.org/10.1007/s40121-021-00517-4
Autor:
Hiroyuki Ito, Shinichi Antoku, Eiji Kusano, Rie Araki, Michiko Togane, Jiro Kondo, Takuma Izutsu, Tomoko Yamasaki, Hideyuki Inoue, Suzuko Matsumoto, Toshiko Mori
Publikováno v:
Diabetol Int
AIMS: The efficacy of dulaglutide was assessed according to the pretreatments administered before the initiation of dulaglutide in patients with type 2 diabetes. METHODS: In total, 89 patients treated using dulaglutide (0.75 mg, once a weekly) were i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e369ab25cfa91a0b4c4cac0a00b0e39
https://doi.org/10.1007/s13340-021-00508-3
https://doi.org/10.1007/s13340-021-00508-3
Autor:
Tomoko Yamasaki, Suzuko Matsumoto, Eiji Kusano, Shinichi Antoku, Toshiko Mori, Michiko Togane, Hiroyuki Ito, Takuma Izutsu
Publikováno v:
Clinical and Experimental Nephrology. 24:1033-1043
To determine the renal and cardiovascular prognosis and all-cause mortality of Japanese patients with type 2 diabetes showing a reduced estimated glomerular filtration rate (eGFR) without albuminuria. A population of 675 patients with type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500e7ae409d45d3bdb7ede2559040132
https://doi.org/10.1007/s10157-020-01935-3
https://doi.org/10.1007/s10157-020-01935-3
Autor:
Hiroyuki Ito, Mina Nakashima, Kentaro Meguro, Haruki Furukawa, Hitomi Yamashita, Akifusa Takaki, Chizuko Yukawa, Takashi Omoto, Masahiro Shinozaki, Shinya Nishio, Mariko Abe, Shinichi Antoku, Mizuo Mifune, Michiko Togane
Publikováno v:
Journal of Diabetes Research, Vol 2015 (2015)
We aimed to clarify the usefulness of measuring the flow mediated dilatation (FMD) in patients with type 2 diabetes mellitus without and with coronary heart disease (CHD). The FMD was measured in 480 patients with type 2 diabetes and in 240 nondiabet
Externí odkaz:
https://doaj.org/article/22a0ec735a534d1896e82df617e243cd
Autor:
Takuma Izutsu, Michiko Togane, Shigenori Ando, Suzuko Matsumoto, Tomoko Yamasaki, Toshiko Mori, Shinya Nishio, Hiroyuki Ito, Shinichi Antoku, Emiko Tsugami, Eiji Kusano
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Hiroyuki Ito1, Suzuko Matsumoto1, Takuma Izutsu1, Eiji Kusano1, Shinya Nishio1, Shinichi Antoku1, Tomoko Yamasaki1, Toshiko Mori1, Michiko Togane1, Shigenori Ando2, Emiko Tsugami2 1Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bece7e10b1b767d599eb7d24e60c5ac
https://doi.org/10.2147/dmso.s221655
https://doi.org/10.2147/dmso.s221655
Autor:
Michiko Togane, Suzuko Matsumoto, Rie Araki, Kosuke Uemura, Tomoko Yamasaki, Toshiko Mori, Hiroyuki Ito, Emiko Tsugami, Eiji Kusano, Shinichi Antoku, Shigenori Ando, Shinya Nishio
Publikováno v:
Diabetes Research and Clinical Practice. 153:41-48
Aims The changes in patients’ satisfaction with the treatment, medication adherence and unused drugs before and after switching from daily DPP-4 inhibitors to once-weekly trelagliptin administration were prospectively investigated in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97816dcd5d42196d5ca7b40c23e7d345
https://doi.org/10.1016/j.diabres.2019.05.025
https://doi.org/10.1016/j.diabres.2019.05.025
Autor:
Shigenori Ando, Hiroyuki Ito, Suzuko Matsumoto, Toshiko Mori, Tomoko Yamasaki, Shinya Nishio, Emiko Tsugami, Kosuke Uemura, Michiko Togane, Shinichi Antoku, Rie Araki
Publikováno v:
Journal of Drug Assessment
Objective: We compared the clinical course of type 2 diabetic patients whose basal insulin preparations were replaced from insulin glargine (IGlar) 100 units/mL (U100) to IGlar biosimilar or IGlar 300 units/mL (U300). Methods: After propensity score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c96ed836eef13d6f25a7f7d277b625
http://europepmc.org/articles/PMC6127835
http://europepmc.org/articles/PMC6127835